Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer is a phase 2, interventional study registered as NCT07397442 by Beijing Friendship Hospital, with a registry enrolment figure of 19 participants, started 2026-03-01 and due to reach its primary completion in 2027-12-31. Interventions recorded: Short-Course Radiotherapy Combined with Chemotherapy and Immunotherapy. Conditions listed: Rectal Cancer, Adenocarcinoma; Rectal Cancer Stage II; Rectal Cancer Stage III. Primary outcome: Complete response rate. Colorectal eligibility wording from the registry: "Rectal adenocarcinoma confirmed by colonoscopic pathology, with pMMR or MSS". Sites: China. No results are recorded here; the registry entry is the source.